title: Type 1 diabetes immunotherapy: is the glass half empty or half full?
abstract: Reevaluation of clinical data from the recent failed immunotherapy trials suggests that researchers should continue the quest to cure type 1 diabetes with immune therapies.
authors.affiliation: Departments of Immunobiology and Internal Medicine, Yale University, New Haven, CT 06511, USA.
authors.forename: Kevan C
authors.initials: KC
authors.lastname: Herold
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Bluestone
mesh_terms: D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy / Q000276:immunology* / Q000628:therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007167:Immunotherapy
chemical_list: D007004:Hypoglycemic Agents